Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain.
Torralba M, Rodríguez G, González Gasca FJ, Cuadra F, Barberá J, Geijo P, Silva A, García MI, Ostaiza MA, García Pérez AM, Arroyo E, Larrubia JR, Gutiérrez A, Porras ML, Calvo Sánchez H, Peña-Asensio J, Arias JG, Mendoza I. Torralba M, et al. Ann Pharmacother. 2024 Feb;58(2):140-147. doi: 10.1177/10600280231168852. Epub 2023 May 2. Ann Pharmacother. 2024. PMID: 37131300
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.
Ruiz-Algueró M, Hernando V, Marcos H, Gutiérrez G, Pérez-Elías MJ, López-Bernaldo de Quirós JC, Pulido F, Górgolas M, Sanz J, Suarez-García I, Fernandez MT, Losa JE, Pérez JL, Ladrero MO, Prieto MÁ, González G, Izquierdo A, Viloria LJ, López I, Martínez E, Castrillejo D, Aranguren R, Belmonte MA, Aranda-García IV, Arraiza A, Diaz A; Hospital Survey Study Group. Ruiz-Algueró M, et al. BMC Infect Dis. 2021 Jan 30;21(1):129. doi: 10.1186/s12879-021-05815-3. BMC Infect Dis. 2021. PMID: 33516173 Free PMC article.
Model to predict on-treatment restoration of functional HBV-specific CD8+ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.
Peña-Asensio J, Calvo H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Aliment Pharmacol Ther. 2022 Jun;55(12):1545-1559. doi: 10.1111/apt.16850. Epub 2022 Feb 27. Aliment Pharmacol Ther. 2022. PMID: 35224746 Free PMC article.
Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply.
Peña-Asensio J, Calvo H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Aliment Pharmacol Ther. 2022 Oct;56(8):1312-1313. doi: 10.1111/apt.17212. Aliment Pharmacol Ther. 2022. PMID: 36168258 No abstract available.
HBsAg level defines different clinical phenotypes of HBeAg(-) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.
Peña-Asensio J, Calvo-Sánchez H, Miquel-Plaza J, Sanz-de-Villalobos E, González-Praetorius A, Delgado-Fernandez A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Front Immunol. 2024 Mar 13;15:1352929. doi: 10.3389/fimmu.2024.1352929. eCollection 2024. Front Immunol. 2024. PMID: 38545116 Free PMC article.
204 results